Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.90% | 194.18 | 1.2% | $592.16m | |
| GILD | Gilead Sciences, Inc. | -0.83% | 69.20 | 0.9% | $496.51m | |
| BIIB | Biogen Inc. | 0.72% | 324.05 | 1.3% | $476.94m | |
| CELG | Celgene Corporation | -0.47% | 69.65 | 1.2% | $474.00m | |
| ILMN | Illumina, Inc. | 0.13% | 319.93 | 3.5% | $402.89m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.08% | 345.33 | 2.6% | $297.08m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.94% | 165.11 | 1.9% | $277.86m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.89% | 118.62 | 2.0% | $201.35m | |
| A | Agilent Technologies, Inc. | 0.42% | 64.99 | 1.5% | $188.27m | |
| EXAS | Exact Sciences Corporation | 3.65% | 71.38 | 25.3% | $147.45m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.07% | 119.04 | 15.4% | $145.09m | |
| LGND | Ligand Pharmaceuticals Incorporated | 1.68% | 154.46 | 23.3% | $145.09m | |
| ECYT | Endocyte, Inc. | 0.25% | 23.67 | 2.0% | $124.13m | |
| INCY | Incyte Corporation | 2.28% | 66.51 | 2.5% | $117.76m | |
| NKTR | Nektar Therapeutics | 0.11% | 38.23 | 5.6% | $117.70m |
Company Profile
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.